Employees Retirement System Of Texas Vir Biotechnology, Inc. Transaction History

Employees Retirement System Of Texas

  • $11.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$30.97 - $54.03 $1.86 Million - $3.24 Million
-60,000 Reduced 67.42%
29,000 $1.21 Million
Q3 2021

Nov 12, 2021
BUY
$34.9 - $54.54 $3.11 Million - $4.85 Million
89,000 New
89,000 $3.87 Million
Q1 2021

May 14, 2021
SELL
$26.34 - $83.07 $3.21 Million - $10.1 Million
-122,000 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$25.51 - $43.38 $3.11 Million - $5.29 Million
122,000 New
122,000 $3.27 Million

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email